AstraZeneca wins temporary block on Actavis asthma drug – 4-traders (press release)


IBTimes.co.uk

AstraZeneca wins temporary block on Actavis asthma drug
4-traders (press release)
AstraZeneca (>> AstraZeneca plc) has secured a temporary block on U.S. sales of generic copies of its Pulmicort Repsules asthma drug by Actavis (>> Actavis Inc). AstraZeneca (>> AstraZeneca plc) has secured a temporary block on U.S. sales of generic
AstraZeneca Loses US Patent Protection for Asthma DrugFox Business
AstraZeneca's Kid Asthma Drug Patent Invalid, Judge SaysLaw360 (subscription)
Blow for AstraZeneca in USA over asthma drug patentsPharmaTimes
IBTimes.co.uk –Globes –Evening Standard
all 37 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.